RhumbLine Advisers’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $539K | Sell |
14,115
-803
| -5% | -$25.4K | ﹤0.01% | 2565 |
|
|
2025
Q4 | $326K | Sell |
14,918
-2,863
| -16% | -$59.5K | ﹤0.01% | 2923 |
|
|
2025
Q3 | $382K | Sell |
17,781
-10,217
| -36% | -$229K | ﹤0.01% | 2866 |
|
|
2025
Q2 | $718K | Buy |
27,998
+11,615
| +71% | +$340K | ﹤0.01% | 2430 |
|
|
2025
Q1 | $600K | Sell |
16,383
-4,331
| -21% | -$149K | ﹤0.01% | 2459 |
|
|
2024
Q4 | $635K | Sell |
20,714
-551
| -3% | -$18.3K | ﹤0.01% | 2515 |
|
|
2024
Q3 | $801K | Buy |
21,265
+985
| +5% | +$38K | ﹤0.01% | 2388 |
|
|
2024
Q2 | $803K | Buy |
20,280
+48
| +0.2% | +$1.55K | ﹤0.01% | 2362 |
|
|
2024
Q1 | $680K | Buy |
20,232
+377
| +2% | +$12.7K | ﹤0.01% | 2475 |
|
|
2023
Q4 | $662K | Sell |
19,855
-329
| -2% | -$10.6K | ﹤0.01% | 2499 |
|
|
2023
Q3 | $633K | Sell |
20,184
-4,054
| -17% | -$128K | ﹤0.01% | 2470 |
|
|
2023
Q2 | $768K | Sell |
24,238
-2,002
| -8% | -$64.7K | ﹤0.01% | 2438 |
|
|
2023
Q1 | $867K | Buy |
26,240
+3,184
| +14% | +$104K | ﹤0.01% | 2188 |
|
|
2022
Q4 | $742K | Buy |
23,056
+561
| +2% | +$19.1K | ﹤0.01% | 2283 |
|
|
2022
Q3 | $804K | Buy |
22,495
+6,553
| +41% | +$272K | ﹤0.01% | 2260 |
|
|
2022
Q2 | $655K | Buy |
15,942
+1,837
| +13% | +$89.2K | ﹤0.01% | 2345 |
|
|
2022
Q1 | $817K | Sell |
14,105
-1,301
| -8% | -$71.2K | ﹤0.01% | 2212 |
|
|
2021
Q4 | $905K | Sell |
15,406
-190
| -1% | -$11.5K | ﹤0.01% | 2251 |
|
|
2021
Q3 | $947K | Buy |
15,596
+598
| +4% | +$35.1K | ﹤0.01% | 2240 |
|
|
2021
Q2 | $900K | Buy |
14,998
+2,000
| +15% | +$100K | ﹤0.01% | 2290 |
|
|
2021
Q1 | $613K | Sell |
12,998
-800
| -6% | -$32.9K | ﹤0.01% | 2396 |
|
|
2020
Q4 | $519K | Buy |
13,798
+800
| +6% | +$26.4K | ﹤0.01% | 2430 |
|
|
2020
Q3 | $425K | Sell |
12,998
-4,102
| -24% | -$174K | ﹤0.01% | 2359 |
|
|
2020
Q2 | $775K | Buy |
17,100
+4,094
| +31% | +$209K | ﹤0.01% | 2152 |
|
|
2020
Q1 | $594K | Buy |
13,006
+63
| +0.5% | +$2.85K | ﹤0.01% | 2106 |
|
|
2019
Q4 | $559K | Buy |
12,943
+445
| +4% | +$18.1K | ﹤0.01% | 2312 |
|
|
2019
Q3 | $452K | Buy |
12,498
+590
| +5% | +$24.9K | ﹤0.01% | 2367 |
|
|
2019
Q2 | $560K | Sell |
11,908
-1,385
| -10% | -$58.5K | ﹤0.01% | 2318 |
|
|
2019
Q1 | $467K | Sell |
13,293
-135
| -1% | -$5.31K | ﹤0.01% | 2350 |
|
|
2018
Q4 | $502K | Buy |
13,428
+4,191
| +45% | +$164K | ﹤0.01% | 2296 |
|
|
2018
Q3 | $313K | Hold |
9,237
| – | – | ﹤0.01% | 2495 |
|
|
2018
Q2 | $230K | Buy |
9,237
+105
| +1% | +$2.92K | ﹤0.01% | 2669 |
|
|
2018
Q1 | $273K | Sell |
9,132
-475
| -5% | -$15.9K | ﹤0.01% | 2480 |
|
|
2017
Q4 | $308K | Sell |
9,607
-1,671
| -15% | -$53.8K | ﹤0.01% | 2458 |
|
|
2017
Q3 | $336K | Sell |
11,278
-122
| -1% | -$3.34K | ﹤0.01% | 2506 |
|
|
2017
Q2 | $266K | Sell |
11,400
-980
| -8% | -$22.8K | ﹤0.01% | 2618 |
|
|
2017
Q1 | $271K | Buy |
12,380
+461
| +4% | +$10.4K | ﹤0.01% | 2551 |
|
|
2016
Q4 | $269K | Sell |
11,919
-444
| -4% | -$10.7K | ﹤0.01% | 2539 |
|
|
2016
Q3 | $283K | Sell |
12,363
-2,280
| -16% | -$50.9K | ﹤0.01% | 2514 |
|
|
2016
Q2 | $313K | Buy |
14,643
+573
| +4% | +$18K | ﹤0.01% | 2503 |
|
|
2016
Q1 | $483K | Buy |
14,070
+660
| +5% | +$17.4K | ﹤0.01% | 2246 |
|
|
2015
Q4 | $369K | Buy |
13,410
+1,155
| +9% | +$31.6K | ﹤0.01% | 2445 |
|
|
2015
Q3 | $366K | Buy |
12,255
+575
| +5% | +$18.8K | ﹤0.01% | 2427 |
|
|
2015
Q2 | $492K | Buy |
+11,680
| New | +$551K | ﹤0.01% | 2341 |
|
Other funds holding ATEX
OCAM
HCL
VCM
QF
PM
GI
RhumbLine Advisers's ATEX Position: Q1 2026 in Review
RhumbLine Advisers reduced its Anterix (ATEX) stake by 5.4% in Q1 2026, selling an estimated $25.4K and leaving 14,115 shares worth $539K. The position accounts for ﹤0.01% of the portfolio, ranked #2565.
RhumbLine Advisers first reported a position in ATEX in Q2 2015 and has held it in 44 quarters since. The position peaked at $947K in Q3 2021. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.
- RhumbLine Advisers held 14,115 shares of Anterix worth $539K as of Q1 2026.
- RhumbLine Advisers sold 803 Anterix shares in Q1 2026, an estimated $25.4K.
- Anterix made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #2565 holding.
- RhumbLine Advisers first reported a position in Anterix in Q2 2015 and has held it in 44 quarters since.
- RhumbLine Advisers's Anterix position peaked at $947K in Q3 2021.
- 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.
Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.